Phosphorylation of mammalian cytosolic and mitochondrial malate dehydrogenase: insights into regulation.

MDH kinase malate dehydrogenase metabolism phosphorylation post translational modification

Journal

Essays in biochemistry
ISSN: 1744-1358
Titre abrégé: Essays Biochem
Pays: England
ID NLM: 0043306

Informations de publication

Date de publication:
12 Jun 2024
Historique:
received: 12 03 2024
revised: 21 05 2024
accepted: 23 05 2024
medline: 12 6 2024
pubmed: 12 6 2024
entrez: 12 6 2024
Statut: aheadofprint

Résumé

Malate dehydrogenase (MDH) is a key enzyme in mammalian metabolic pathways in cytosolic and mitochondrial compartments. Regulation of MDH through phosphorylation remains an underexplored area. In this review we consolidate evidence supporting the potential role of phosphorylation in modulating the function of mammalian MDH. Parallels are drawn with the phosphorylation of lactate dehydrogenase, a homologous enzyme, to reveal its regulatory significance and to suggest a similar regulatory strategy for MDH. Comprehensive mining of phosphorylation databases, provides substantial experimental (primarily mass spectrometry) evidence of MDH phosphorylation in mammalian cells. Experimentally identified phosphorylation sites are overlaid with MDH's functional domains, offering perspective on how these modifications could influence enzyme activity. Preliminary results are presented from phosphomimetic mutations (serine/threonine residues changed to aspartate) generated in recombinant MDH proteins serving as a proof of concept for the regulatory impact of phosphorylation. We also examine and highlight several approaches to probe the structural and cellular impact of phosphorylation. This review highlights the need to explore the dynamic nature of MDH phosphorylation and calls for identifying the responsible kinases and the physiological conditions underpinning this modification. The synthesis of current evidence and experimental data aims to provide insights for future research on understanding MDH regulation, offering new avenues for therapeutic interventions in metabolic disorders and cancer.

Identifiants

pubmed: 38864157
pii: 234552
doi: 10.1042/EBC20230079
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Auteurs

Joseph J Provost (JJ)

Department of Chemistry and Biochemistry, University of San Diego, San Diego CA, U.S.A.

Kathleen A Cornely (KA)

Department of Chemistry and Biochemistry, Providence College, Providence RI, U.S.A.

Pamela S Mertz (PS)

Department of Chemistry and Biochemistry, St. Mary's College of Maryland, St. Mary's City, MD, U.S.A.

Celeste N Peterson (CN)

Department of Biology, Suffolk University, Boston, MA, U.S.A.

Sophie G Riley (SG)

Department of Chemistry and Biochemistry, University of San Diego, San Diego CA, U.S.A.

Harrison J Tarbox (HJ)

Department of Chemistry and Biochemistry, University of San Diego, San Diego CA, U.S.A.

Shree R Narasimhan (SR)

Department of Chemistry and Biochemistry, University of San Diego, San Diego CA, U.S.A.

Andrew J Pulido (AJ)

Department of Chemistry and Biochemistry, University of San Diego, San Diego CA, U.S.A.

Amy L Springer (AL)

Department of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, MA, U.S.A.

Classifications MeSH